Drug Profile
SM 6586
Alternative Names: SM-6586Latest Information Update: 14 Oct 2005
Price :
$50
*
At a glance
- Originator Sumitomo Pharmaceuticals
- Class Antihypertensives
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cerebrovascular disorders; Hypertension
Most Recent Events
- 21 Jul 2000 Discontinued-I for Hypertension and Cerebrovascular disease in Japan